PT101461B - NUTRIENT LIQUID FOR NEWBORN - Google Patents
NUTRIENT LIQUID FOR NEWBORN Download PDFInfo
- Publication number
- PT101461B PT101461B PT10146194A PT10146194A PT101461B PT 101461 B PT101461 B PT 101461B PT 10146194 A PT10146194 A PT 10146194A PT 10146194 A PT10146194 A PT 10146194A PT 101461 B PT101461 B PT 101461B
- Authority
- PT
- Portugal
- Prior art keywords
- liquid nutrient
- mmol
- sodium
- electrolytes
- potassium
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 20
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 9
- 239000011734 sodium Substances 0.000 claims abstract description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003792 electrolyte Substances 0.000 claims abstract description 8
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 8
- 239000011591 potassium Substances 0.000 claims abstract description 8
- 208000005735 Water intoxication Diseases 0.000 abstract description 5
- 229920002774 Maltodextrin Polymers 0.000 abstract description 3
- 239000005913 Maltodextrin Substances 0.000 abstract description 3
- 229940035034 maltodextrin Drugs 0.000 abstract description 3
- 230000002028 premature Effects 0.000 abstract 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000036033 hyponatraemia Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
A presente invenção refere-se a um nutriente líquido para recém-nascidos de acordo com a introdução da reivindicação 1.The present invention relates to a liquid nutrient for newborns according to the introduction of claim 1.
É já conhecido um nutriente líquido desta natureza da Descrição DE-PS 2 457 733.A liquid nutrient of this nature is already known from Description DE-PS 2 457 733.
Com este nutriente líquido é possível fornecer oralmente aos recém-nascidos e aos prematuros energia em quantidade suficiente, podendo ser administrado líquido suficiente devido à relativamente reduzida osmolaridade, de modo que não ocorra a chamada febre da sede.With this liquid nutrient, it is possible to supply newborns and premature babies with sufficient energy orally, and sufficient liquid can be administered due to the relatively low osmolarity, so that the so-called thirst fever does not occur.
Na realidade os nutrientes líquidos conhecidos estão associados ao risco de provocarem uma intoxicação hídrica se for administrado demasiado líquido num período de tempo curto.In fact, the known liquid nutrients are associated with the risk of causing water poisoning if too much liquid is administered in a short period of time.
Como consequência deste estado de perigo de vida surgem vómitos, edemas pulmonares, dispneia, reduzida secreção de urina, bem como perturbações da função cardíaca.As a consequence of this life-threatening state, vomiting, pulmonary edema, dyspnoea, reduced urine secretion, and disturbances in cardiac function arise.
A invenção resulta pois da necessidade de se pôr à disposição um nutriente líquido do tipo descrito que não cause intoxicação hídrica, mesmo para doses elevadas.The invention therefore results from the need to provide a liquid nutrient of the type described that does not cause water intoxication, even at high doses.
Este problema é solucionado de acordo com a invenção adicionando-se ao nutriente líquido electrólitos na forma de sódio, potássio e cloreto.This problem is solved according to the invention by adding electrolytes to the liquid nutrient in the form of sodium, potassium and chloride.
Através da adição destes electrólitos impede-se uma intoxicação hídrica, fornecendo-se apesar disso ao recémnascido energia em quantidade suficiente.By adding these electrolytes, water intoxication is prevented, yet the newborn is supplied with sufficient energy.
notável aperfeiçoamento dos nutrientes líquidos conduz também a que não ocorra uma hiponatriémia, como acontece em recém-nascidos que foram alimentados apenas com maltodextrina e nos quais o nível do sódio no sangue é demasiado baixo.a remarkable improvement in liquid nutrients also leads to hyponatraemia not occurring, as in newborns who were fed only maltodextrin and in which the level of sodium in the blood is too low.
A adição de electrólitos, que de resto também estão presentes no sangue do cordão umbilical e no colostro, deverá fazer-se, de harmonia com uma variante de realização vantajosaThe addition of electrolytes, which are also present in the umbilical cord blood and colostrum, should be done, in harmony with a variant of advantageous realization
-1 da invenção, numa gama de 20 a 40 mmol/1 de sódio, 5 a 20 mmol/1 de potássio e 20 a 60 mmol/1 de cloreto. Adiciona-se ao nutriente líquido de preferência uma proporção de 30 mmol/1 de í-1 of the invention, in a range of 20 to 40 mmol / 1 of sodium, 5 to 20 mmol / 1 of potassium and 20 to 60 mmol / 1 of chloride. Preferably, a ratio of 30 mmol / 1 μl is added to the liquid nutrient.
sódio, 10 mmol/1 de potássio e 40 mmol/1 de cloreto. A osmolaridade situa-se neste caso em cerca de 200 mosmol/í.sodium, 10 mmol / 1 potassium and 40 mmol / 1 chloride. In this case, osmolarity is about 200 mosmol / µ.
Lisboa, 14 de Fevereiro de 1994 0 AGEITE OFICIAL DA PBOPEIEDADE LXDfSIEIALLisbon, February 14, 1994 0 OFFICIAL AGEITE OF PBOPEIEDADE LXDfSIEIAL
-21. Nutriente líquido para recém-nascidos com uma proporção de a 45% em peso de maltodextrina, no qual a osmolaridade total do nutriente líquido não ultrapassa 350 mosmol/1, caracterizado por se adicionarem electrólitos na forma de sódio, potássio e cloreto.-21. Liquid nutrient for newborns with a proportion of 45% by weight of maltodextrin, in which the total osmolarity of the liquid nutrient does not exceed 350 mosmol / 1, characterized by the addition of electrolytes in the form of sodium, potassium and chloride.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT10146194A PT101461B (en) | 1994-02-14 | 1994-02-14 | NUTRIENT LIQUID FOR NEWBORN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT10146194A PT101461B (en) | 1994-02-14 | 1994-02-14 | NUTRIENT LIQUID FOR NEWBORN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT101461A PT101461A (en) | 1995-09-12 |
| PT101461B true PT101461B (en) | 1997-06-30 |
Family
ID=20085366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT10146194A PT101461B (en) | 1994-02-14 | 1994-02-14 | NUTRIENT LIQUID FOR NEWBORN |
Country Status (1)
| Country | Link |
|---|---|
| PT (1) | PT101461B (en) |
-
1994
- 1994-02-14 PT PT10146194A patent/PT101461B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT101461A (en) | 1995-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Welt et al. | The consequences of potassium depletion | |
| Anwer et al. | Hepatotoxic bile acids increase cytosolic Ca++ activity of isolated rat hepatocytes | |
| Tidball | Magnesium and calcium as regulators of intestinal permeability | |
| Jabs et al. | Prostaglandin E2 inhibits Na+-K+-ATPase activity in the inner medullary collecting duct | |
| Rasmussen et al. | Thyrocalcitonin, osteoporosis and osteolysis | |
| ES2048428T3 (en) | COMPOSITIONS OF IBUPROPHEN FOR ORAL ADMINISTRATION. | |
| Erecińska et al. | Neuronal glutamine utilization: glutamine/glutamate homeostasis in synaptosomes | |
| Ksiezak‐Reding et al. | Studies on the pyruvate dehydrogenase complex in brain with the arylamine acetyltransferase‐coupled assay | |
| Perez et al. | Modulation of intestinal paracellular permeability by intracellular mediators and cytoskeleton | |
| Reibel et al. | Coenzyme A metabolism in pantothenic acid-deficient rats | |
| Edwards | Accumulation of taurine by cultured retinal pigment epithelium of the rat. | |
| Miller et al. | Dietary Lactose Improves Endochondral Growth and Bone Development and Mineralization in Rats Fed a Vitamin D—Deficient Diet | |
| Kleinman et al. | Renal response of the new-born dog to a saline load: the role of intrarenal blood flow distribution | |
| Erecińska | Stimulation of the Na+/K+ pump activity during electrogenic uptake of acidic amino acid transmitters by rat brain synaptosomes | |
| Okuda et al. | Effects of ethylenediaminetetraacetate and metal ions in intestinal absorption of vitamin B12 in man and rats | |
| Goglia et al. | The effect of thyroid state on respiratory activities of three rat liver mitochondrial fractions | |
| GB520753A (en) | Improvements in photographic developers | |
| Haralambie | Serum glycoproteins and physical exercise | |
| Rigault et al. | Respiration and oxidative phosphorylation by mitochondria of red and white skeletal muscle | |
| Baudouin-Legros et al. | Hypertonic NaCl enhances adenosine release and hormonal cAMP production in mouse thick ascending limb | |
| Ho et al. | Metabolic control of renal vascular resistance and glomerulotubular balance | |
| LASSILA et al. | Impact of streptozotocin‐induced diabetes on rat blood and alveolar bone affected by occlusal stress | |
| Ma et al. | Serum osteocalcin and calcitonin in adult males with different fluoride exposures | |
| Rhoden et al. | Evidence of Na-K-Cl cotransport in airway smooth muscle | |
| Richter et al. | High-affinity glutamine uptake of the rat hippocampus during postnatal development: a quantitative autoradiographic study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19970319 |
|
| MM3A | Annulment or lapse |
Effective date: 20050816 |